Abeona Therapeutics (ABEO) Non-Current Assets (2010 - 2026)

Abeona Therapeutics' Non-Current Assets history runs 17 years deep, the most recent figure standing at $15.5 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 37.94% year-over-year to $15.5 million; the TTM figure through Mar 2026 stood at $59.1 million (up 67.19% YoY), while the FY2025 annual figure was $14.7 million, up 81.53% from the prior year.
• Non-Current Assets was $15.5 million for Q1 2026 at Abeona Therapeutics, up from $14.7 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $16.0 million in Q1 2022 to a low of $7.9 million in Q3 2024.
• Historically, Non-Current Assets has averaged $11.4 million across 5 years, with a median of $11.1 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Non-Current Assets tumbled 74.05% in 2022, then soared 88.59% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $11.1 million in 2022, then slipped by 25.64% to $8.3 million in 2023, then declined by 2.26% to $8.1 million in 2024, then jumped by 81.53% to $14.7 million in 2025, then rose by 5.76% to $15.5 million in 2026.
• The last three Non-Current Assets figures came in at $15.5 million (Q1 2026), $14.7 million (Q4 2025), and $15.0 million (Q3 2025), per Business Quant data.